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The carotid body has long been recognized as the body’s primary acute oxygen sensor. For decades,
this organ has been reluctant to reveal mechanisms underlying its sensory activity. In this issue of Cell
Metabolism, Fernandez-Agu¨era et al. (2015) take us closer to a fuller understanding of this fundamental
process.The existence of the carotid body, a tiny
structure (approximately 10 mg in man)
found at the bifurcation of the common
carotid arteries, has been acknowledged
for more than two centuries. Only with
the exquisite anatomical studies of de
Castro, however, followed shortly there-
after by functional studies particularly by
Heymans (father and son) in the early
20th century, do we now know it functions
as a sensory organ (see Kumar and Prab-
hakar, 2012 for a review). It has an
extremely high blood supply and is a pol-
ymodal sensor of arterial blood, respond-
ing to changes in pO2, pH, pCO2, glucose,
and other agents, by altering afferent
nerve activity that in turn powerfully influ-
ences central control of ventilation and
other sympathetically driven cardiovas-
cular activities. It is a sensor of acute
hypoxia—at levels that other tissues
would fail to notice—that has generated
most scientific interest. Furthermore, the
carotid body plays important roles in
cardiorespiratory diseases such as hyper-
tension and heart failure (Kumar and
Prabhakar, 2012).
Within the carotid body, type I (glomus)
cells cluster tightly in small groups
closely apposed to both blood vessels
and afferent sensory nerves. These
transmitter-filled cells have long been
considered the sensory elements of this
organ. In the late 1980s, a handful of
groups independently developed prepa-
rations of isolated type I cells, allowing
accessibility to multiple cell biological
techniques. Rapid progress was sub-
sequently made toward understanding
the cellular basis of O2 sensing. Lo´pez-
Barneo’s group and collaborators in
Valladolid demonstrated that these cellsexpressed K+ channels which were
rapidly and reversibly inhibited by acute
hypoxia (Lo´pez-Barneo et al., 1988). For
some time, controversies around this
topic simmered (Kumar and Prabhakar,
2012) but eventually distilled into what
is accepted now as the membrane hy-
pothesis for chemoreception (Prabhakar
and Peers, 2014). Put simply, the hypoth-
esis states that hypoxia (among other
stimuli, as mentioned above) inhibits K+
channels, causing membrane depolariza-
tion and consequent voltage-gated Ca2+
entry, which is sufficient to trigger trans-
mitter release and so excite afferent
nerves, thereby exerting powerful cardio-
respiratory effects. The key question
since then has been ‘‘how?’’ How does
a fall in pO2 lead rapidly to K
+ channel in-
hibition? While numerous ideas have
been proposed (Peers et al., 2010), a uni-
form agreement as to this fundamental
process has not been forthcoming. How-
ever, mitochondria have long been impli-
cated, since the suggestion made almost
45 years ago by Mills and Jo¨bsis (1972)
that the carotid body may possess a cy-
tochrome oxidase with unusual O2 affin-
ity. The work of Fernandez-Agu¨era et al.
(2015), published in this issue, places
mitochondria firmly center stage and,
crucially, points to complex I of the elec-
tron transport chain as being a key
element for oxygen sensing. It also
brings to prominence once again a
signaling role for reactive oxygen species
(ROS).
Fundamental to this study, Fernandez-
Agu¨era et al. (2015) generated a knockout
mouse that lacked the 49kD protein,
Ndufs-2, specifically in catecholaminergic
cells including type I cells (and adrenalCell Metabolism 22,chromaffin cells, also studied in this pa-
per). Ndufs2 forms part of the ubiquinone
binding site (where the classical inhibitor
rotenone binds to inhibit ubiquinone
reduction). Without Ndufs-2, the ability
of complex I to perform its physiological
role of catalyzing NADH oxidation, ubiqui-
none reduction, and H+ transport is highly
impaired. However, the cells were not
markedly bioenergetically compromised,
because of unusually high activity of suc-
cinate-dependent oxidative phosphoryla-
tion. Lo´pez-Barneo and colleagues had
previously shown that rotenone, one of
the many mitochondrial inhibitors that
were known to mimic/occlude effects of
hypoxia in the carotid body, was particu-
larly effective, thus leading them to sug-
gest a key role for complex I in O2 sensing
over 10 years ago (Ortega-Sa´enz et al.,
2003).
While the responses to most chemosti-
muli of type I cells from Ndufs-2-deficient
mice remained intact, they showed an
impressive lack of sensitivity to hypoxia,
as assessed by several different ap-
proaches, including intact hypoxic venti-
latory responses, amperometric trans-
mitter detection, [Ca2+]i measurements,
and NAD(P)H autofluorescence. Key to
the membrane hypothesis, the authors
used patch-clamp recordings to demon-
strate a lack of effect of hypoxia on K+
channels in these cells. In fact, it ap-
peared that K+ channels in Ndufs-2-defi-
cient mice were under tonic inhibition
(and were depolarized as compared with
control cells). Buffering of intracellular
ROS relieved this inhibition, but not
in control cells. Conversely, in control
cells, oxidants mimicked and occluded
hypoxic inhibition of K+ channels, effectsNovember 3, 2015 ª2015 Elsevier Inc. 753
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The implication from these observations
was that hypoxia inhibits K+ channels
(the fundamental step in the membrane
hypothesis) via a complex I-dependent
mechanism that involves a rise of
ROS to modulate K+ channels, possibly
directly. This was further supported by
fluorescence imaging of reversible hypox-
ic rises of ROS in mitochondria of control
cells, while Ndufs-2 cells showed gener-
ally raised mitochondrial ROS levels but
no obvious hypoxic response.
Emerging from these data is the overall
proposal that hypoxia may slow type I cell
electron transport and cause reduced
quinone accumulation, leading to a highly
reduced state in complex I. In this state
(which may even reverse its activity)
ROS production and concomitant NADH
accumulation occurs rapidly and both
may contribute to inhibition of K+ chan-
nels. The process does not involve alter-
ations in ATP levels, which are maintained
via succinate/complex II.
This study will provoke excitement and
debate within and beyond the field of754 Cell Metabolism 22, November 3, 2015 ªchemoreception. It supports the once
controversial idea that ROS levels in-
crease rather than decrease during hyp-
oxia (Guzy and Schumacker, 2006). It
also places mitochondria as central
to O2 sensing, but not via reduced
ATP formation. It does not conflict with
the concept of a cytochrome oxidase
with unusual O2 affinity (Mills and Jo¨bsis,
1972); data have emerged supporting
this suggestion (Duchen and Biscoe,
1992;Buckler and Turner, 2013), but it re-
mains to be determined exactly how hyp-
oxia disrupts mitochondrial activity in
such a specialized way. However, what
we do know now, due to this multidisci-
plinary, comprehensive and compelling
study (Fernandez-Agu¨era et al., 2015) is
that complex I is essential in coupling
pO2 to K
+ channel regulation.
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Microbe communicationwith hostmammalian cells and external factors such as diet influences thismultifac-
eted ecosystem. A recent study shows that interactions between microbial genes and dietary elements are
dynamic processes that may help to characterize an organism’s niche and eventually its impact on the overall
community and host metabolism.Substantial evidence exists showing that
gut microbiota can be considered an
exteriorized organ involved in a myriad
of interactions with our body cells.
Mammalian gut microbiota is a dynamic
community that rapidly changes and
adapts to specific environmental shifts
such as diet (e.g., low-fat versus high-
fat) and therefore nutrient availability(Cani and Everard, 2015). However, mi-
crobial genetic determinants involved in
community assembly, resilience, and sta-
bility are poorly studied.
In a recent report in Science, Wu et al.
identified genetic factors determining
how gut microbiota may adapt to environ-
mental perturbation such as diet (Wu
et al., 2015). To address this, they devel-oped a new method able to monitor ge-
netic changes in the gut bacteria and
reveal the selective pressure induced by
diet, by combining gnotobiotic animals,
dietary interventions, and mutant bacte-
rial strains.
The authors focused on a prominent
genus of the human gut of four
commonly found strains of Bacteroides
